Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Feasibility Trial To Study The Safety Of Sealing Resected Pancreatic Surfaces After Partial Distal Pancreatectomy Using Laser Tissue Welding

NCT03147768 is registered in ClinicalTrials.gov with Laser Tissue Welding, Inc. as lead sponsor.

NCT NCT03147768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Feasibility Trial To Study The Safety Of Sealing Resected Pancreatic Surfaces After Partial Distal Pancreatectomy Using Laser Tissue Welding
Lead sponsor
Laser Tissue Welding, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2018
Completion date
December 31, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas injury, pancreas; insulinoma, pancreatic adenocarcinoma, pancreatic cyst, pancreatic cystadenoma, pancreatic gastrinoma, pancreatic glucagonoma, pancreatic neoplasms, pancreatic neuroendocrine tumor, pancreatic polypeptide tumor, pancreatic pseudocyst, pancreatic teratoma, pancreatic tumor, benign, pancreatic vipoma